Previous Close | 9.86 |
YTD Return | 1.67% |
Expense Ratio (net) | 1.14% |
Category | High Yield Bond |
Last Cap Gain | 0.00 |
Morningstar Rating | ★★★★★ |
Morningstar Risk Rating | Below Average |
Sustainability Rating | N/A |
Net Assets | 1.52B |
Beta (5Y Monthly) | 0.44 |
Yield | 4.28% |
5y Average Return | N/A |
Holdings Turnover | 64.00% |
Last Dividend | 0.04 |
Average for Category | N/A |
Inception Date | Dec 17, 2012 |
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
NEW YORK, NY / ACCESSWIRE / February 9, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:GW Pharmaceuticals plc (NASDAQ:GWPH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Jazz Pharmaceuticals plc for $200.00 in Jazz ordinary shares for each GW American Depositary Share (ADS).